3Varvel JR, Sharer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology, 1989,70:928.
二级参考文献17
1Becker N. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain, 1997,7:393-400.
3Portenoy RK. Opioid therapy for chronic non-malignant pain: a review of critical issues. J Pain Symptom Manage, 1996,11:203-217.
4Dellemijn PLI, Vanneste JAL. Randomized double-blind active-placebocontrolled crossover trial of intravenous fentanyl in neuropathic pain.Lancet, 1997,349:753-758.
5Arkinstall W, Sandier A, Goughnour B, et al. Efficacy of controlledrelease codeine in chronic nonmalisnant pain: a randomized, placebocontrolled clinical trial. Pain , 1995,62 : 169-178.
6Jamixon RN. Comprehensive pretreatment and outcome assessment for chromic opioid therapy in non-cancer pain. J Pain Symptom Manage,1996,11:231-241.
7Richant P, Sonja C, Meredith E. Guidelines for the clinical use of transdermal fentanyl. Anti-Cancer Drugs, 1995,6 (Suppl 3):50-53.
8Richard BR, Antona J. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs , 2001,61:2289-2307.
9Wendy J, Paul B. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in pain control. Drugs,1997,53 : 109-138.
10Allan L, Hays H, Jensen NH, et al. Randomized croesover trial of transdermal fentanyl and sustained released oral morphine for treating chronic non-cancer pain.BMJ,2001,322:1154-1158.
4Sommer M, de Rijke JM van Kleef M, et al. The prevalence of postoperative pain in a sample of 1490 surgical inpatients. EurJ Anaesthesiol, 2008, 25(4) :267-274.
5Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev, 2012, 3 CD004233.
6LuscombeKS, McDonnell NJ, Muchatuta NA, et al. A ran domised comparison of parecoxib versus placebo for pain man agement following minor day stay gynaecological surgery. An aesth Intensive Care, 2010, 38(1) 141-148.
7Hay JL, White JM, Bochner F, et al. Hyperalgesia in opioid- managed chronic pain and opioid-dependent patients. J Pain, 2009, 10(3): 316-322.
8Akbari E. The role of cyclo-oxygenase inhihitors in attenua- ting opioid-indueed tolerance, hyperalgesia, and dependence. Med Hypotheses, 2012, 78(1).- 102-106.
9Lenzmeier B, Moore RL, Cordts P, et al. Menstrual cycle-re- lated variations in postoperative analgesia with the preemptive use of N-methyl D-aspartate antagonist ketamine: a pilot study. Dimens Crit Care Nurs, 2008, 27(6): 271-276.
10Kiribayashi M, Inagaki Y, Nishimura Y, et al. Caudal block- ade shortens the time to walking exercise in elderly patients following low back surgery. J Anesth, 2010, 24(2)I 192-196.
